Search Articles

View query in Help articles search

Search Results (1 to 10 of 624 Results)

Download search results: CSV END BibTex RIS


A Deep Learning–Enabled Workflow to Estimate Real-World Progression-Free Survival in Patients With Metastatic Breast Cancer: Study Using Deidentified Electronic Health Records

A Deep Learning–Enabled Workflow to Estimate Real-World Progression-Free Survival in Patients With Metastatic Breast Cancer: Study Using Deidentified Electronic Health Records

This clinician-confirmed cancer progression in unstructured text (ie, clinical notes) has been shown to serve as a reasonable surrogate for real-world indicators in ascertaining progression endpoints. This is also more practical for real-world studies than purely RECIST-based approaches [6].

Gowtham Varma, Rohit Kumar Yenukoti, Praveen Kumar M, Bandlamudi Sai Ashrit, K Purushotham, C Subash, Sunil Kumar Ravi, Verghese Kurien, Avinash Aman, Mithun Manoharan, Shashank Jaiswal, Akash Anand, Rakesh Barve, Viswanathan Thiagarajan, Patrick Lenehan, Scott A Soefje, Venky Soundararajan

JMIR Cancer 2025;11:e64697

Analyzing Usage of the Metaverse by Associations of Patients With Prostate Cancer During the 2023 Blue Ribbon Campaign: Cross-Sectional Survey Study

Analyzing Usage of the Metaverse by Associations of Patients With Prostate Cancer During the 2023 Blue Ribbon Campaign: Cross-Sectional Survey Study

Prostate cancer is the second-most common cancer among men worldwide and the most common urologic malignancy in high-income countries. In 2020, there were an estimated 1,414,000 diagnosed cases and 375,304 deaths related to prostate cancer [1]. It is important to note that prostate cancer can progress without symptoms, leading to missed treatment opportunities [2].

Jung Ki Jo, Yeeun Kim, Yun-Sok Ha, Kwang Taek Kim, Sangjun Yoo, Woo Suk Choi, Jihye Yang, Jaeeun Shin, Sun Il Kim, Jeong Hyun Kim

J Med Internet Res 2025;27:e63030

Process Re-Engineering and Data Integration Using Fast Healthcare Interoperability Resources for the Multidisciplinary Treatment of Lung Cancer

Process Re-Engineering and Data Integration Using Fast Healthcare Interoperability Resources for the Multidisciplinary Treatment of Lung Cancer

According to the requirements of the Taiwan National Cancer Diagnosis and Treatment Quality Certification, MDT meetings must be held regularly every year to discuss new diagnostic cases. However, the treatment course for patients with cancer is long, and patients are often cared for by different clinical departments.

Ching-Hsiung Lin, Bing-Yen Wang, Sheng-Hao Lin, Pei Hsuan Shih, Chin-Jing Lee, Yung Ting Huang, Shih Chieh Chen, Mei-Lien Pan

JMIR Cancer 2025;11:e53887

Examining Practices Related to Ethical Aspects in eHealth Evaluation Research: Protocol for a Scoping Review

Examining Practices Related to Ethical Aspects in eHealth Evaluation Research: Protocol for a Scoping Review

RPM shows particular promise in the care of cancer [3,4] and cardiovascular diseases [5], as these conditions often require prompt intervention when health issues arise. Together, they account for more than half of global mortality, with 33% attributed to cancer and 18% to cardiovascular diseases [6].

Linda Wienands, Sabine Valenta, Lynn Leppla, Sabina De Geest, László Kovács, Alexandra Teynor, Julia Krumme

JMIR Res Protoc 2025;14:e60849

Education and Symptom Reporting in an mHealth App for Patients With Cancer: Mixed Methods Development and Validation Study

Education and Symptom Reporting in an mHealth App for Patients With Cancer: Mixed Methods Development and Validation Study

According to the World Health Organization (WHO), cancer is one of the leading causes of mortality worldwide. In 2020, approximately 19 million people were diagnosed, and 9.3 million people die each year [1,2]. In the particular context of Chile, a comparable pattern was noted; in the same year, 54,000 cases of cancer were diagnosed, with 28,000 fatalities attributed to the disease annually.

Carolina Muñoz Olivar, Miguel Pineiro, Juan Sebastián Gómez Quintero, Carlos Javier Avendaño-Vásquez, Pablo Ormeño-Arriagada, Silvia Palma Rivadeneira, Carla Taramasco Toro

JMIR Hum Factors 2025;12:e60169

A Digital Outpatient Service With a Mobile App for Tailored Care and Health Literacy in Adults With Long-Term Health Service Needs: Multicenter Nonrandomized Controlled Trial

A Digital Outpatient Service With a Mobile App for Tailored Care and Health Literacy in Adults With Long-Term Health Service Needs: Multicenter Nonrandomized Controlled Trial

Patients were recruited from the department of respiratory diseases, the department of neurology, and the department of pain management and research at the Oslo University Hospital as well as the department of cancer at the University Hospital of North Norway. Eligible patients were required to be aged ≥18 years, based at home, and capable of completing questionnaires in Norwegian.

Heidi Holmen, Are Martin Holm, Ragnhild Sørum Falk, Thomas Karsten Kilvær, Tone Marte Ljosaa, Christopher Ekholdt, Erik Fosse

J Med Internet Res 2025;27:e60343

Primary Tumors of the Brain and Central Nervous System in Adults and Children in Sub-Saharan Africa: Protocol for a Scoping Review

Primary Tumors of the Brain and Central Nervous System in Adults and Children in Sub-Saharan Africa: Protocol for a Scoping Review

A significant proportion of new cancer cases worldwide are estimated to occur in low- and middle-income countries (LMICs), but the true prevalence is underestimated due to limited diagnostic capacities [1,2]. Sub-Saharan Africa (SSA) faces challenges in providing the necessary oncology and neurology services for the management of central nervous system (CNS) tumors.

Alhasan Ahmed Badeea Al-Fikri, Mesk Alhammadi, Chiedozie Arum, Mahima Kaur, Kayla Del Biondo, Ibrahim Bani, Victor Mudenda, Sten H Vermund

JMIR Res Protoc 2025;14:e66978

The Efficacy of Digital Interventions on Adherence to Oral Systemic Anticancer Therapy Among Patients With Cancer: Systematic Review and Meta-Analysis

The Efficacy of Digital Interventions on Adherence to Oral Systemic Anticancer Therapy Among Patients With Cancer: Systematic Review and Meta-Analysis

Patients with cancer aged 18 years and older. Patients diagnosed with cancer. Patients with cancer taking oral SACTsa. Patients with cancer including pediatrics, children, adolescents, neonates, or infants. Studies that include mixed age groups of participants with cancer. Patients with cancer taking nonoral SACTsa. Patients with cancer exclusively receiving injectable SACTsa.

Wan-Chuen Liao, Fiona Angus, Jane Conley, Li-Chia Chen

JMIR Cancer 2025;11:e64208

Web-Based Explainable Machine Learning-Based Drug Surveillance for Predicting Sunitinib- and Sorafenib-Associated Thyroid Dysfunction: Model Development and Validation Study

Web-Based Explainable Machine Learning-Based Drug Surveillance for Predicting Sunitinib- and Sorafenib-Associated Thyroid Dysfunction: Model Development and Validation Study

Variables including patient demographics, cancer-related information, medication use, laboratory tests, coexisting drugs, and comorbidities were collected from the CRD. Patient demographics including age, gender, and cancer-related information were collected once at the baseline.

Fan-Ying Chan, Yi-En Ku, Wen-Nung Lie, Hsiang-Yin Chen

JMIR Form Res 2025;9:e67767